IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v15y2018i4p572-d137586.html
   My bibliography  Save this article

Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses

Author

Listed:
  • Masaya M. Saito

    (The Institute of Statistical Mathematics, 10-3 Midori-cho, Tachikawa, Tokyo 190-8562, Japan
    Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan)

  • Keisuke Ejima

    (Institute of Industrial Science, The University of Tokyo, Tokyo 153-8505, Japan
    School of Public Health, Indiana University Bloomington, 1025 E 7th St #111, Bloomington, IN 47405, USA)

  • Ryo Kinoshita

    (Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
    Graduate School of Medicine, Hokkaido University, Kita 15 Jo Nishi 7 Chome, Kita-ku, Sapporo, Hokkaido 060-9638, Japan)

  • Hiroshi Nishiura

    (Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency, 4-1-8 Honcho, Kawaguchi, Saitama 332-0012, Japan
    Graduate School of Medicine, Hokkaido University, Kita 15 Jo Nishi 7 Chome, Kita-ku, Sapporo, Hokkaido 060-9638, Japan)

Abstract

Elevating herd immunity level against rubella is essential to prevent congenital rubella syndrome (CRS). Insufficient vaccination coverage left susceptible pockets among adults in Japan, and the outbreak of rubella from 2012 to 2013 resulted in 45 observed CRS cases. Given a limited stock of rubella-containing vaccine (RCV) available, the Japanese government recommended healthcare providers to prioritize vaccination to those confirmed with low level of immunity, or to those likely to transmit to pregnant women. Although a test-and-vaccinate policy could potentially help reduce the use of the limited stockpile of vaccines, by selectively elevating herd immunity, the cost of serological testing is generally high and comparable to the vaccine itself. Here, we aimed to examine whether random vaccination would be more cost-beneficial than the test-and-vaccinate strategy. A mathematical model was employed to evaluate the vaccination policy implemented in 2012–2013, quantifying the benefit-to-cost ratio to achieve herd immunity. The modelling exercise demonstrated that, while the test-and-vaccinate strategy can efficiently achieve herd immunity when stockpiles of RCV are limited, random vaccination would be a more cost-beneficial strategy. As long as the herd immunity acts as the goal of vaccination, our findings apply to future supplementary immunization strategy.

Suggested Citation

  • Masaya M. Saito & Keisuke Ejima & Ryo Kinoshita & Hiroshi Nishiura, 2018. "Assessing the Effectiveness and Cost-Benefit of Test-and-Vaccinate Policy for Supplementary Vaccination against Rubella with Limited Doses," IJERPH, MDPI, vol. 15(4), pages 1-12, March.
  • Handle: RePEc:gam:jijerp:v:15:y:2018:i:4:p:572-:d:137586
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/15/4/572/pdf
    Download Restriction: no

    File URL: https://www.mdpi.com/1660-4601/15/4/572/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Pedro Plans, 2010. "Prevalence of Antibodies Associated with Herd Immunity: A New Indicator to Evaluate the Establishment of Herd Immunity and to Decide Immunization Strategies," Medical Decision Making, , vol. 30(4), pages 438-443, July.
    2. Carol Y. Lin, 2008. "Modeling Infectious Diseases in Humans and Animals by KEELING, M. J. and ROHANI, P," Biometrics, The International Biometric Society, vol. 64(3), pages 993-993, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Kazuki Shimizu & Ayaka Teshima & Hiromi Mase, 2020. "Measles and Rubella during COVID-19 Pandemic: Future Challenges in Japan," IJERPH, MDPI, vol. 18(1), pages 1-11, December.
    2. Taishi Kayano & Hyojung Lee & Hiroshi Nishiura, 2019. "Modelling a Supplementary Vaccination Program of Rubella Using the 2012–2013 Epidemic Data in Japan," IJERPH, MDPI, vol. 16(8), pages 1-11, April.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Tyagi, Swati & Martha, Subash C. & Abbas, Syed & Debbouche, Amar, 2021. "Mathematical modeling and analysis for controlling the spread of infectious diseases," Chaos, Solitons & Fractals, Elsevier, vol. 144(C).
    2. Kimberly M. Thompson, 2016. "Evolution and Use of Dynamic Transmission Models for Measles and Rubella Risk and Policy Analysis," Risk Analysis, John Wiley & Sons, vol. 36(7), pages 1383-1403, July.
    3. Wei Zhong, 2017. "Simulating influenza pandemic dynamics with public risk communication and individual responsive behavior," Computational and Mathematical Organization Theory, Springer, vol. 23(4), pages 475-495, December.
    4. De Martino, Giuseppe & Spina, Serena, 2015. "Exploiting the time-dynamics of news diffusion on the Internet through a generalized Susceptible–Infected model," Physica A: Statistical Mechanics and its Applications, Elsevier, vol. 438(C), pages 634-644.
    5. John M Drake & Tobias S Brett & Shiyang Chen & Bogdan I Epureanu & Matthew J Ferrari & Éric Marty & Paige B Miller & Eamon B O’Dea & Suzanne M O’Regan & Andrew W Park & Pejman Rohani, 2019. "The statistics of epidemic transitions," PLOS Computational Biology, Public Library of Science, vol. 15(5), pages 1-14, May.
    6. Christel Kamp & Mathieu Moslonka-Lefebvre & Samuel Alizon, 2013. "Epidemic Spread on Weighted Networks," PLOS Computational Biology, Public Library of Science, vol. 9(12), pages 1-10, December.
    7. Guido M. Kuersteiner & Ingmar R. Prucha, 2020. "Dynamic Spatial Panel Models: Networks, Common Shocks, and Sequential Exogeneity," Econometrica, Econometric Society, vol. 88(5), pages 2109-2146, September.
    8. Moritz Kersting & Andreas Bossert & Leif Sörensen & Benjamin Wacker & Jan Chr. Schlüter, 2021. "Predicting effectiveness of countermeasures during the COVID-19 outbreak in South Africa using agent-based simulation," Palgrave Communications, Palgrave Macmillan, vol. 8(1), pages 1-15, December.
    9. Ofosuhene O Apenteng & Noor Azina Ismail, 2014. "The Impact of the Wavelet Propagation Distribution on SEIRS Modeling with Delay," PLOS ONE, Public Library of Science, vol. 9(6), pages 1-9, June.
    10. Miguel Navascués & Costantino Budroni & Yelena Guryanova, 2021. "Disease control as an optimization problem," PLOS ONE, Public Library of Science, vol. 16(9), pages 1-32, September.
    11. Frank Daumann & Florian Follert & Werner Gleißner & Endre Kamarás & Chantal Naumann, 2021. "Political Decision Making in the COVID-19 Pandemic: The Case of Germany from the Perspective of Risk Management," IJERPH, MDPI, vol. 19(1), pages 1-23, December.
    12. M Gabriela M Gomes & Marc Lipsitch & Andrew R Wargo & Gael Kurath & Carlota Rebelo & Graham F Medley & Antonio Coutinho, 2014. "A Missing Dimension in Measures of Vaccination Impacts," PLOS Pathogens, Public Library of Science, vol. 10(3), pages 1-3, March.
    13. Wiriya Mahikul & Somkid Kripattanapong & Piya Hanvoravongchai & Aronrag Meeyai & Sopon Iamsirithaworn & Prasert Auewarakul & Wirichada Pan-ngum, 2020. "Contact Mixing Patterns and Population Movement among Migrant Workers in an Urban Setting in Thailand," IJERPH, MDPI, vol. 17(7), pages 1-11, March.
    14. Carnehl, Christoph & Fukuda, Satoshi & Kos, Nenad, 2023. "Epidemics with behavior," Journal of Economic Theory, Elsevier, vol. 207(C).
    15. Sterck, Olivier, 2016. "Natural resources and the spread of HIV/AIDS: Curse or blessing?," Social Science & Medicine, Elsevier, vol. 150(C), pages 271-278.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:15:y:2018:i:4:p:572-:d:137586. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.